Scarica l'app Stockscreener
1.68
1.20%
0.02
Fate Therapeutics Inc Azioni (FATE) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
14.86%
1.925
|
1.676 | 1.944 | 0.933 | 58.98 |
Operating Expenses
|
6.52%
52.99
|
49.75 | 53.22 | 63.50 | 87.57 |
| Benefits Costs and Expenses |
9.02%
49.93
|
45.80 | - | - | 77.86 |
| Costs And Expenses |
9.02%
49.93
|
45.80 | 53.22 | 63.50 | 77.86 |
| Operating Income/Loss |
6.23%
-51.07
|
-48.08 | -51.28 | -62.56 | -28.59 |
| Income/Loss From Continuing Operations Before Tax |
8.80%
-48.00
|
-44.12 | 1.944 | -52.76 | -18.88 |
| Income/Loss From Continuing Operations After Tax |
8.80%
-48.00
|
-44.12 | -45.17 | -52.76 | -18.88 |
|
Net Income/Loss
|
8.80%
-48.00
|
-44.12 | -45.17 | -52.76 | -18.88 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
148.01K%
101.10
|
0.0683 | 98.57 | 98.40 | 98.05 |
| Diluted Average Shares |
148.01K%
101.10
|
0.0683 | 98.57 | 98.40 | 98.05 |
| Basic Earnings Per Share |
4.44%
-0.47
|
-0.45 | -0.46 | -0.54 | -0.19 |
| Diluted Earnings Per Share |
4.44%
-0.47
|
-0.45 | -0.46 | -0.54 | -0.19 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.88%
2.65%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):